These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 34239350)
1. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment. Xu W; Liu WR; Xu Y; Tian X; Anwaier A; Su JQ; Zhu WK; Shi GH; Wei GM; Huang YP; Qu YY; Zhang HL; Ye DW Int J Biol Sci; 2021; 17(9):2205-2222. PubMed ID: 34239350 [No Abstract] [Full Text] [Related]
2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma. Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D Front Immunol; 2021; 12():734646. PubMed ID: 34795663 [TBL] [Abstract][Full Text] [Related]
3. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
4. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration. Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993 [TBL] [Abstract][Full Text] [Related]
5. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
6. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816 [TBL] [Abstract][Full Text] [Related]
7. Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC. Zhang W; Zhao E; Li Z; Liu W; Wang J; Hou W; Zhang N; Yu Y; Li X; You B Cell Death Dis; 2024 Aug; 15(8):613. PubMed ID: 39179546 [TBL] [Abstract][Full Text] [Related]
8. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma. Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357 [TBL] [Abstract][Full Text] [Related]
9. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma. Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral CXCL13 Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528 [TBL] [Abstract][Full Text] [Related]
11. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC). Liu S; Li S; Wang Y; Wang F; Zhang L; Xian S; Yang D; Yuan M; Dai F; Zhao X; Liu Y; Jin Y; Zeng Z; Mahgoub OKA; Zhou C; Cheng Y J Cell Biochem; 2020 Mar; 121(3):2571-2581. PubMed ID: 31823423 [TBL] [Abstract][Full Text] [Related]
13. Glioma hexokinase 3 positively correlates with malignancy and macrophage infiltration. Liang T; Zhou X; Wang Y; Ma W Metab Brain Dis; 2024 Jun; 39(5):719-729. PubMed ID: 38687460 [TBL] [Abstract][Full Text] [Related]
14. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity. Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484 [TBL] [Abstract][Full Text] [Related]
15. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications. Wang Q; Hu J; Kang W; Wang J; Xiang Y; Fu M; Gao H; Huang Z Medicine (Baltimore); 2021 Mar; 100(11):e24949. PubMed ID: 33725966 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion. Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904 [TBL] [Abstract][Full Text] [Related]
18. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment. Dong X; Gu DN; Wang O; Ye Z Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma. Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study. Wang YQ; Chen WJ; Zhou W; Dong KQ; Zuo L; Xu D; Chen JX; Chen WJ; Li WY; Liu ZC; Jiang ZY; Tang YF; Qin YX; Wang LH; Pan XW; Cui XG J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38908856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]